A pioneering NHS initiative aimed at preserving and reconditioning donor organs could significantly increase transplant rates across England, marking a major technological step forward in the delivery of life-saving care.
The pilot scheme, led by NHS Blood and Transplant, is being rolled out across a network of specialist hospitals and focuses on extending the time donor organs can be safely preserved outside the body. Early analysis suggests the approach could enable up to 750 additional transplants each year, representing a potential 19 per cent increase in activity. With more than 8,000 patients currently waiting for transplants in the UK, the initiative is being positioned as a critical intervention to address long-standing shortages in organ availability.
Extending preservation through advanced perfusion technology
At the heart of the scheme is the use of advanced machine perfusion technology, which replaces the traditional method of storing organs on ice. Instead, organs are maintained in a near-physiological state using oxygenated blood or nutrient-rich fluids circulated through specialised devices. This innovation dramatically extends preservation times, from just a few hours to potentially 12–24 hours for some organs, and longer in certain cases, giving clinicians more time to assess organ viability and plan complex procedures.
The additional time window addresses a key limitation in current transplant pathways, where organs are often declined due to uncertainty about their condition or lack of time for thorough testing. By enabling real-time functional assessment, perfusion systems allow clinicians to make more confident decisions about whether an organ can be safely transplanted. Crucially, the technology also opens the door to future innovations, including the possibility of repairing or enhancing organs before transplantation using regenerative therapies or targeted treatments.
National network of assessment and recovery centres
The pilot forms part of a broader strategy to establish a national network of Assessment and Recovery Centres (ARCs) which are specialised facilities designed to optimise the evaluation and utilisation of donor organs. Initial pilot sites are focusing on lungs, with early centres launched at major transplant hospitals including Royal Papworth Hospital in Cambridge, alongside additional sites planned in Newcastle and London. Kidney and liver programmes are expected to follow as the network expands.
The ARC model represents a shift towards centralised, technology-enabled transplant infrastructure. Rather than relying solely on individual hospitals to assess organs under tight time constraints, the network aims to standardise processes and create centres of excellence. Over time, this could support more consistent clinical decision-making, improved outcomes and greater efficiency across the transplant system.
Data, AI and the future of transplant decision-making
Beyond preservation technology, the scheme reflects a wider trend towards data-driven and AI-supported transplantation. Emerging tools are already being developed to assess organ quality using advanced analytics, helping clinicians determine suitability more accurately. Research backed by the National Institute for Health and Care Research has demonstrated how AI-based systems can “score” donor organs, potentially increasing the number of viable transplants while reducing the risk of failure.
When combined with perfusion technology, such tools could transform transplant pathways by integrating real-time physiological data with predictive modelling. This would enable more precise matching of organs to recipients and support more efficient use of scarce resources. The integration of digital platforms, remote monitoring and national data infrastructure will also be critical to scaling the ARC network, ensuring seamless coordination between retrieval teams, laboratories and surgical units.
Addressing a growing gap between supply and demand
The urgency of innovation in this area is underscored by persistent shortages in donor organs. Despite the introduction of an opt-out donation system in England, demand continues to outstrip supply, with waiting lists remaining at record levels. At the same time, the profile of donors is changing. As populations age and more individuals live with chronic conditions, a greater proportion of available organs require careful assessment before use. The new preservation and assessment technologies directly address this challenge by increasing the proportion of organs deemed suitable for transplantation. In some cases, organs that would previously have been discarded may now be safely utilised.
Implications for NHS digital and clinical strategy
The scheme highlights how advanced technology is becoming central to the future of NHS care delivery. By combining biomedical engineering, data analytics and clinical expertise, the transplant system is evolving into a highly digital, precision-driven model. If successfully scaled, the initiative could not only reduce waiting times and save lives, but also serve as a blueprint for wider adoption of technology-enabled care pathways across the NHS.
For health technology leaders, the development signals a shift towards integrated, innovation-led service design, where infrastructure, data and clinical practice are aligned to deliver measurable improvements in outcomes. As the pilot progresses, its success will be closely watched as an example of how targeted investment in technology can unlock capacity and transform one of the most complex areas of modern healthcare.
